1. Home
  2. NUVL vs AAON Comparison

NUVL vs AAON Comparison

Compare NUVL & AAON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$99.35

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo AAON Inc.

AAON

AAON Inc.

HOLD

Current Price

$81.95

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
AAON
Founded
2017
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
6.8B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
NUVL
AAON
Price
$99.35
$81.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
4
Target Price
$135.33
$107.75
AVG Volume (30 Days)
454.6K
795.5K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
N/A
$1,442,076,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,064.25
$15.07
P/E Ratio
N/A
$63.29
Revenue Growth
N/A
20.11
52 Week Low
$55.54
$62.00
52 Week High
$113.02
$116.04

Technical Indicators

Market Signals
Indicator
NUVL
AAON
Relative Strength Index (RSI) 45.24 31.45
Support Level $98.37 $74.95
Resistance Level $107.13 $86.88
Average True Range (ATR) 3.78 5.34
MACD -0.30 -2.00
Stochastic Oscillator 29.49 3.14

Price Performance

Historical Comparison
NUVL
AAON

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About AAON AAON Inc.

AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.

Share on Social Networks: